Still Seeking New Growth Areas, Cephalon Reassures Investors It Can Continue To Build Nuvigil And Treanda
This article was originally published in The Pink Sheet Daily
Executive Summary
Cephalon highlighted the life-cycle management of its existing franchises during an R&D day held in New York on Nov. 18, with a focus on Nuvigil and Treanda.